reference/18052773

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18052773

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study
endingPage	23
issn	0939-5555 1432-0584
issueIdentifier	1
pageRange	15-23
publicationName	Annals of Hematology
startingPage	15
bibliographicCitation	Kim DY, Lee JH, Lee JH, Lee KH, Kim YK, Ahn JS, Kim HJ, Kim I, Yoon SS, Park S, Bae SH, Bang SM, Lee HG, Shin HJ, Lee JH, Min YH, Won JH, Mun YC, Oh D; Korean Society of Hematology AML/MDS Working Party. Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Ann Hematol. 2010 Jan;89(1):15–23. doi: 10.1007/s00277-009-0771-1. PMID: 19543727.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b9bdd1e3d520e17aa537df0ee21725b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_831950a480b0b40a0f7f09be0a635e0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2d49a1a7586c39b66c3b2a02df83f86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fcb9fd2586225a3a8ebcc3a5f4e78a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b54f6b95e1f23bfd29886903b2a715a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14839eb9436b66994ed47caa16cb6cf8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7060-1675 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6091934bd1b71cfc595b21921450b5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7945087bd457b3fed087214cdbb17de3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27f5e02e37dac7ce339191a12bf86f16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed45817a0499b53314abe470952d9fc2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f8908ad95329163a74f80ddc949242e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bb3ae926fda875f38434f4d95e38203 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1756371a72d42de6f93eb54746784c5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1882-3983 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeda7308a3f6d2c6bce0e2f6ed797f45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc24470e713ecef82cea3a3b363d7d65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4e7bf7a6075b84fb1c71fb101d75109 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8abb363e04de8ff0cc9340d4bfcb339 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b51bdbfab599255cc3b731fa3b4aec76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeedf35f1494577a66ae7c0156464e22
date	2009-06-19^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00277-009-0771-1 https://pubmed.ncbi.nlm.nih.gov/19543727
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088 https://portal.issn.org/resource/ISSN/1432-0584 https://portal.issn.org/resource/ISSN/0939-5555
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
discusses	http://id.nlm.nih.gov/mesh/M0002060 http://id.nlm.nih.gov/mesh/M0001471
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009190Q000188 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D009190Q000175 http://id.nlm.nih.gov/mesh/D001374Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D015996Q000639 http://id.nlm.nih.gov/mesh/D009190Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128725069

Showing number of triples: 1 to 63 of 63.